Correlation Between Scpharmaceuticals and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Scpharmaceuticals and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Elevation Oncology.
Diversification Opportunities for Scpharmaceuticals and Elevation Oncology
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Elevation is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Elevation Oncology go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Elevation Oncology
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 2.52 times less risky than Elevation Oncology. The stock trades about -0.01 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 95.00 in Elevation Oncology on August 26, 2024 and sell it today you would lose (35.00) from holding Elevation Oncology or give up 36.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Elevation Oncology
Performance |
| Timeline |
| Scpharmaceuticals |
| Elevation Oncology |
Scpharmaceuticals and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Elevation Oncology
The main advantage of trading using opposite Scpharmaceuticals and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |